» Articles » PMID: 18261982

Sequence Determinants Regulating Fibrillation of Human Alpha-synuclein

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2008 Feb 12
PMID 18261982
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

alpha-Synuclein is a neural protein that comprises the fibrillar core of Lewy bodies, a histologically defining lesion of Parkinson's disease. To investigate the role of each specific residue of the alpha-synuclein molecule in fibril formation, amino acid substitutions were introduced throughout the molecule. Incorporation of proline, especially in the region spanning residues 37-89, drastically retarded fibril formation. Substitutions with polar residues showed that the hydrophobicity of the central hydrophobic region is also important in fibrillation regulation. In the N-terminal repeated region, increasing the number of negative charges interfered with fibrillation. In contrast, single amino acid substitutions in the C-terminal acidic region of alpha-synuclein had only minimal effects on fibrillation. More than 20 different single amino acid substitutions that were sufficient to prevent fibrillation of alpha-synuclein were obtained, and most of them were impaired in both nucleation and fibril elongation. Identification of sequence determinants regulating fibrillation of amyloidogenic proteins may provide valuable information for designing peptide analog drugs to prevent protein amyloidosis.

Citing Articles

Advancing Parkinson's diagnosis: seed amplification assay for α-synuclein detection in minimally invasive samples.

Carrazana E, Montalban-Gutierrez L, Chana-Cuevas P, Salvadores N Mol Cell Biochem. 2025; .

PMID: 39760833 DOI: 10.1007/s11010-024-05190-y.


High-Yield α-Synuclein Purification and Ionic Strength Modification Pivotal to Seed Amplification Assay Performance and Reproducibility.

Janarthanam C, Clabaugh G, Wang Z, Melvin B, Scheibe I, Jin H Int J Mol Sci. 2024; 25(11).

PMID: 38892177 PMC: 11172462. DOI: 10.3390/ijms25115988.


Relationship among α‑synuclein, aging and inflammation in Parkinson's disease (Review).

Zhang N, Yan Z, Xin H, Shao S, Xue S, Cespuglio R Exp Ther Med. 2023; 27(1):23.

PMID: 38125364 PMC: 10728906. DOI: 10.3892/etm.2023.12311.


Peptide-based approaches to directly target alpha-synuclein in Parkinson's disease.

Allen S, Meade R, White Stenner L, Mason J Mol Neurodegener. 2023; 18(1):80.

PMID: 37940962 PMC: 10633918. DOI: 10.1186/s13024-023-00675-8.


Disease-Specific α-Synuclein Seeding in Lewy Body Disease and Multiple System Atrophy Are Preserved in Formaldehyde-Fixed Paraffin-Embedded Human Brain.

Kim A, Martinez-Valbuena I, Li J, Lang A, Kovacs G Biomolecules. 2023; 13(6).

PMID: 37371515 PMC: 10296376. DOI: 10.3390/biom13060936.